Search

everythinglearnresearchcommunity

for

Search:↓

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Finasteride, a medication, is being re-evaluated for its effects and uses.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

5-alpha reductase inhibitors slightly increase depression risk, but the risk varies based on the control group used.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

5α-Reductase inhibitors can negatively impact sexual function.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Taking medication for hair loss might cause sexual problems.

5-Alpha-Reductase Inhibitors can cause negative side effects.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.